• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Fibrinolysis Shutdown and Thrombosis in Severe COVID-19.

作者信息

Seheult Jansen N, Seshadri Anupamaa, Neal Matthew D

机构信息

Pittsburgh, PA.

出版信息

J Am Coll Surg. 2020 Aug;231(2):203-204. doi: 10.1016/j.jamcollsurg.2020.05.021. Epub 2020 Jun 12.

DOI:10.1016/j.jamcollsurg.2020.05.021
PMID:32593497
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7290169/
Abstract
摘要

相似文献

1
Fibrinolysis Shutdown and Thrombosis in Severe COVID-19.重症 COVID-19 中的纤维蛋白溶解抑制与血栓形成
J Am Coll Surg. 2020 Aug;231(2):203-204. doi: 10.1016/j.jamcollsurg.2020.05.021. Epub 2020 Jun 12.
2
Rescue fibrinolysis in suspected massive pulmonary embolism during SARS-CoV-2 pandemic.2019冠状病毒病大流行期间疑似大面积肺栓塞的挽救性纤溶治疗
Resuscitation. 2020 Jul;152:86-88. doi: 10.1016/j.resuscitation.2020.05.020. Epub 2020 May 20.
3
Fibrinolysis Resistance: A Potential Mechanism Underlying COVID-19 Coagulopathy.纤维蛋白溶解抵抗：新冠病毒感染相关凝血障碍的潜在机制
Thromb Haemost. 2020 Sep;120(9):1343-1345. doi: 10.1055/s-0040-1713637. Epub 2020 Jul 9.
4
Thrombosis and antiphospholipid antibodies in patients with SARS-COV-2 infection (COVID-19).2019冠状病毒病（COVID-19）患者的血栓形成与抗磷脂抗体
Int J Lab Hematol. 2020 Dec;42(6):e280-e282. doi: 10.1111/ijlh.13320. Epub 2020 Aug 26.
5
Thrombosis and COVID-19 pneumonia: the clot thickens!血栓与 COVID-19 肺炎：凝块变厚！
Eur Respir J. 2020 Jul 30;56(1). doi: 10.1183/13993003.01608-2020. Print 2020 Jul.
6
Molecular mechanisms for thrombosis risk in Black people: a role in excess mortality from COVID-19.黑人血栓形成风险的分子机制：在COVID-19导致的过高死亡率中的作用。
Br J Haematol. 2020 Jul;190(2):e78-e80. doi: 10.1111/bjh.16869. Epub 2020 Jun 8.
7
COVID-19 coagulopathy, thrombosis, and bleeding.COVID-19 相关凝血功能障碍、血栓形成和出血。
Blood. 2020 Jul 23;136(4):381-383. doi: 10.1182/blood.2020007335.
8
Coagulopathy and mesenteric ischaemia in severe SARS-CoV-2 infection.重症严重急性呼吸综合征冠状病毒2感染中的凝血功能障碍和肠系膜缺血
ANZ J Surg. 2020 Sep;90(9):1826. doi: 10.1111/ans.16151. Epub 2020 Jul 13.
9
Pulmonary Vascular Pathology in Covid-19.新型冠状病毒肺炎中的肺血管病理学
N Engl J Med. 2020 Aug 27;383(9):887. doi: 10.1056/NEJMc2022068. Epub 2020 Jul 17.
10
Pulmonary Vascular Pathology in Covid-19.新冠病毒肺炎中的肺血管病理学
N Engl J Med. 2020 Aug 27;383(9):886-887. doi: 10.1056/NEJMc2022068. Epub 2020 Jul 17.

引用本文的文献

1
COVID-19: Not a thrombotic disease but a thromboinflammatory disease.COVID-19：不是血栓性疾病，而是血栓炎症性疾病。
Ups J Med Sci. 2024 Jan 22;129. doi: 10.48101/ujms.v129.9863. eCollection 2024.
2
The Role of the Plasminogen/Plasmin System in Inflammation of the Oral Cavity.纤溶酶原/纤溶酶系统在口腔炎症中的作用。
Cells. 2023 Jan 30;12(3):445. doi: 10.3390/cells12030445.
3
D-Dimer as a Sensitive Biomarker of Survival Rate in Patients with COVID-19.D-二聚体作为新型冠状病毒肺炎患者生存率的敏感生物标志物
Eurasian J Med. 2022 Oct;54(3):219-224. doi: 10.5152/eurasianjmed.2022.21145.
4
Protection by metformin against severe Covid-19: An in-depth mechanistic analysis.二甲双胍对严重 COVID-19 的保护作用：深入的机制分析。
Diabetes Metab. 2022 Jul;48(4):101359. doi: 10.1016/j.diabet.2022.101359. Epub 2022 May 31.
5
Activation of the Carboxypeptidase U (CPU, TAFIa, CPB2) System in Patients with SARS-CoV-2 Infection Could Contribute to COVID-19 Hypofibrinolytic State and Disease Severity Prognosis.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染患者中羧肽酶U（CPU，TAFIa，CPB2）系统的激活可能导致新型冠状病毒肺炎（COVID-19）的低纤维蛋白溶解状态和疾病严重程度预后。
J Clin Med. 2022 Mar 9;11(6):1494. doi: 10.3390/jcm11061494.
6
The balance of comprehensive coagulation and fibrinolytic potential is disrupted in patients with moderate to severe COVID-19.在中重度 COVID-19 患者中，全面凝血和纤维蛋白溶解潜能的平衡被打破。
Int J Hematol. 2022 Jun;115(6):826-837. doi: 10.1007/s12185-022-03308-w. Epub 2022 Feb 16.
7
COVID-19, the Pandemic of the Century and Its Impact on Cardiovascular Diseases.2019冠状病毒病，世纪大流行及其对心血管疾病的影响。
Cardiol Discov. 2021 Nov 22;1(4):233-258. doi: 10.1097/CD9.0000000000000038. eCollection 2021 Dec.
8
Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19.纤维蛋白凝块结构改变和纤溶失调导致严重 COVID-19 血栓形成风险增加。
Blood Adv. 2022 Feb 8;6(3):1074-1087. doi: 10.1182/bloodadvances.2021004816.
9
Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin.长期 COVID/COVID-19 后急性后遗症（PASC）中持续存在的凝血蛋白病理学伴随着抗纤溶酶水平的升高。
Cardiovasc Diabetol. 2021 Aug 23;20(1):172. doi: 10.1186/s12933-021-01359-7.
10
Low level of plasminogen increases risk for mortality in COVID-19 patients.纤溶酶原水平低会增加 COVID-19 患者的死亡风险。
Cell Death Dis. 2021 Aug 5;12(8):773. doi: 10.1038/s41419-021-04070-3.

本文引用的文献

1
Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection.严重 COVID-19 感染中纤维蛋白溶解关闭与血栓栓塞事件的相关性。
J Am Coll Surg. 2020 Aug;231(2):193-203.e1. doi: 10.1016/j.jamcollsurg.2020.05.007. Epub 2020 May 15.
2
Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia.危重症 COVID-19 肺炎患者旋转血栓弹性描记术评估凝血功能。
J Thromb Thrombolysis. 2020 Aug;50(2):281-286. doi: 10.1007/s11239-020-02130-7.
3
Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19.新冠病毒肺炎住院患者治疗剂量抗凝与院内生存的相关性
J Am Coll Cardiol. 2020 Jul 7;76(1):122-124. doi: 10.1016/j.jacc.2020.05.001. Epub 2020 May 6.
4
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages.COVID-19 患者的病理性炎症：单核细胞和巨噬细胞的关键作用。
Nat Rev Immunol. 2020 Jun;20(6):355-362. doi: 10.1038/s41577-020-0331-4. Epub 2020 May 6.
5
Incidence of venous thromboembolism in hospitalized patients with COVID-19.COVID-19 住院患者静脉血栓栓塞症的发生率。
J Thromb Haemost. 2020 Aug;18(8):1995-2002. doi: 10.1111/jth.14888. Epub 2020 Jul 27.
6
Targeting potential drivers of COVID-19: Neutrophil extracellular traps.靶向 COVID-19 的潜在驱动因素：中性粒细胞胞外陷阱。
J Exp Med. 2020 Jun 1;217(6). doi: 10.1084/jem.20200652.
7
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.抗凝治疗与伴有凝血功能障碍的严重 2019 冠状病毒病患者的死亡率降低相关。
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
8
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.异常的凝血参数与新型冠状病毒肺炎患者的预后不良有关。
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.
9
Low D-dimer levels in sepsis: Good or bad?脓毒症中低D-二聚体水平：是好是坏？
Thromb Res. 2019 Feb;174:13-15. doi: 10.1016/j.thromres.2018.12.003. Epub 2018 Dec 5.
10
Microparticles and Fibrinolysis.微粒与纤维蛋白溶解
Semin Thromb Hemost. 2017 Mar;43(2):129-134. doi: 10.1055/s-0036-1592301. Epub 2016 Dec 6.